DarioHealth Corp. announced a 20-to-1 reverse stock split of its common stock.
The reverse stock split will be implemented at market open on August 28, 2025.
After the reverse stock split, each 20 common stocks will be combined into 1 stock.
Reverse Stock Split Ratio
The reverse stock split will be at a ratio of 20-for-1, reducing outstanding common stocks from 47,996,572 to approximately 2,399,829.
Board Approval
The reverse stock split was approved by the company's board of directors at the 2025 Annual Meeting of Stockholders on July 23, 2025.
No Impact on Ownership
The reverse stock split will not affect stockholders' percentage ownership or voting power, except for minimal effects due to fractional shares treatment.
Adjustment to Securities
All existing options, convertible securities, restricted stocks, and warrants will be appropriately adjusted after the reverse stock split.
Exchange Agent
VStock Transfer, LLC, will act as the exchange agent for the reverse stock split process.
- The reverse stock split aims to streamline the company's outstanding common stock, enhancing liquidity and potentially influencing trading patterns.
- Stockholders should be aware of the adjustment process for their securities and the impact on trading under the new post-split basis.
This announcement marks a strategic move by DarioHealth Corp. to consolidate its common stock and optimize trading efficiency. Stockholders should stay informed about the process to ensure a seamless transition.